Catheter Precision, Inc.
VTAKAMEXHealthcare● Active
$1.02
$-0.01(-0.97%)
Market Cap$1102083
P/E Ratio—
52W High$15.77
52W Low$0.75
Catheter Precision, Inc. (VTAK) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · VTAK · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.82M | $0.42M | $0.44M | $0.01M | $0.02M |
| Cost of Revenue | $0.06M | $0.04M | $0.03M | $0.16M | $1.56M |
| Gross Profit | $0.76M | $0.38M | $0.41M | ($0.15M) | ($1.54M) |
| Gross Margin %(computed) | 92.31% | 90.00% | 93.21% | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.86M | $0.27M | $0.47M | $6.39M | $12.25M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $12.94M | $11.62M | $78.53M | $26.81M | $27.73M |
| Operating Income | ($12.18M) | ($11.24M) | ($78.12M) | ($26.96M) | ($29.27M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.03M | $0.08M | $0.35M | $0.00M | $0.00M |
| Interest Expense | $0.28M | $0.09M | $0.00M | $0.00M | $0.01M |
| Income Before Tax | ($19.50M) | ($13.50M) | ($70.57M) | ($26.86M) | ($27.26M) |
| Income Tax Expense | ($1.81M) | $3.14M | $0.00M | $0.00M | $0.00M |
| Net Income | ($17.18M) | ($16.64M) | ($70.57M) | ($26.86M) | ($25.07M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-15.90 | $-6.68 | $-12.99 | $-25.98 | $-248.22 |
| Wtd Avg Shares | 1080.62M | 3.26M | 5.50M | 1.03M | 0.10M |
| EBITDA | ($17.11M) | ($11.30M) | ($15.11M) | ($22.37M) | ($25.85M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Catheter Precision, Inc. data
About Catheter Precision, Inc. (VTAK) Income Statement
Catheter Precision, Inc. (VTAK) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, VTAK reported revenue of $0.00B, gross profit of $0.00B (gross margin 92.31%), and net income of ($0.02B) — a net profit margin of -2098.05%.
Frequently asked questions
VTAK · 4 questionsCatheter Precision, Inc. (VTAK) reported revenue of $0.00B for 2025, up 95.0% year-over-year.
VTAK revenueVTAK salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09